Antiplatelet therapy in CVD management: Role of pharmacists

Antiplatelet therapy in CVD management: Role of pharmacists

A badge with ribbon in color black Point(s): 1 | An analog clock in color black 20 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 20 Jan 2022 

Overview

NEW!

MPS Code: 0732/2020

The goal of this learning activity is to provide pharmacists with a concise review of antiplatelet agents in the management of cardiovascular disease (CVD). 

Upon completing this module,participants will have a better understanding of the following aspects:
● Prevalence of CVD
● Pharmacists’ role in CVD management
● P2Y12 inhibitors in patients with acute coronary syndrome (ACS) following percutaneous coronary intervention (PCI)

Who should participate:
Pharmacists

NOTE:
Please read thoroughly & understand the module before attempting the assessment questions.

Terms & Conditions: 
 Participants must obtain a minimum score of 7/10 (70%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points.

The modules/articles are best viewed with:
Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards-compliant browser may be required to view the modules.  

Sponsored by:

SANOFI_logo.jpg